BR112014023193A2 - composto da fórmula geral (i): a[l-ch-ca]p e formulação de vacina - Google Patents
composto da fórmula geral (i): a[l-ch-ca]p e formulação de vacinaInfo
- Publication number
- BR112014023193A2 BR112014023193A2 BR112014023193A BR112014023193A BR112014023193A2 BR 112014023193 A2 BR112014023193 A2 BR 112014023193A2 BR 112014023193 A BR112014023193 A BR 112014023193A BR 112014023193 A BR112014023193 A BR 112014023193A BR 112014023193 A2 BR112014023193 A2 BR 112014023193A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- general formula
- vaccine formulation
- vaccine
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Gram-positive bacteria
- C07K16/1275—Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2012054848 | 2012-03-19 | ||
| PCT/EP2012/002277 WO2013178236A1 (en) | 2012-05-26 | 2012-05-26 | Carbohydrate-glycolipid conjugate vaccines |
| PCT/EP2013/055719 WO2013139803A1 (en) | 2012-03-19 | 2013-03-19 | Carbohydrate-glycolipid conjugate vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014023193A2 true BR112014023193A2 (pt) | 2017-08-01 |
Family
ID=47901120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014023193A BR112014023193A2 (pt) | 2012-03-19 | 2013-03-19 | composto da fórmula geral (i): a[l-ch-ca]p e formulação de vacina |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10588962B2 (https=) |
| EP (1) | EP2827899B1 (https=) |
| JP (2) | JP5933106B2 (https=) |
| KR (1) | KR101675657B1 (https=) |
| CN (1) | CN104321079A (https=) |
| AR (1) | AR090386A1 (https=) |
| AU (1) | AU2013237497B2 (https=) |
| BR (1) | BR112014023193A2 (https=) |
| CA (1) | CA2866978C (https=) |
| CY (1) | CY1116706T1 (https=) |
| DK (1) | DK2827899T3 (https=) |
| ES (1) | ES2551599T3 (https=) |
| HK (1) | HK1205682A1 (https=) |
| HU (1) | HUE028144T2 (https=) |
| IL (1) | IL234604A (https=) |
| MX (1) | MX337202B (https=) |
| PL (1) | PL2827899T3 (https=) |
| PT (1) | PT2827899E (https=) |
| RU (1) | RU2649009C2 (https=) |
| SG (1) | SG11201405646TA (https=) |
| SI (1) | SI2827899T1 (https=) |
| TW (1) | TWI633112B (https=) |
| WO (1) | WO2013139803A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2851092A1 (en) * | 2013-09-18 | 2015-03-25 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3 |
| WO2016152980A1 (ja) * | 2015-03-24 | 2016-09-29 | 国立大学法人岐阜大学 | オリゴヌクレオチド誘導体及びそれを用いたオリゴヌクレオチド構築物並びにそれらの製造方法 |
| CN106565800B (zh) * | 2015-10-08 | 2019-08-13 | 中国人民解放军第二军医大学 | 三糖对甲氧基苯酚苷类化合物及其制备方法 |
| TWI732825B (zh) * | 2016-05-20 | 2021-07-11 | 日商王子控股股份有限公司 | 圖案形成用定向自組裝組成物、圖案形成用定向自組裝組成物用單體及圖案形成方法 |
| CN106620682A (zh) * | 2017-01-19 | 2017-05-10 | 华中师范大学 | 一种脂质体疫苗制剂及其用途和生产IgG抗体的方法 |
| CN111065387B (zh) | 2017-09-07 | 2023-08-25 | 默沙东有限责任公司 | 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途 |
| CN107955082B (zh) * | 2017-12-11 | 2019-05-10 | 江南大学 | 幽门螺旋杆菌脂多糖外核心八糖的制备方法 |
| CN115515965B (zh) * | 2020-01-10 | 2024-12-24 | 南特大学 | 新型免疫刺激剂及其在免疫治疗中的用途 |
| CN111760021B (zh) * | 2020-05-18 | 2023-06-16 | 广州中医药大学(广州中医药研究院) | 一种含有α-半乳糖神经酰胺类似物与糖抗原的缀合物及其制备方法和应用 |
| CN111760020B (zh) * | 2020-05-18 | 2023-05-26 | 广州中医药大学(广州中医药研究院) | 一种缀合物及其制备方法和应用 |
| KR102915939B1 (ko) * | 2024-07-01 | 2026-01-21 | 코스맥스에이비 주식회사 | 피부상재균을 이용한 극성지질 발효물의 제조방법 및 이를 포함하는 화장료 조성물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5936076A (en) | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
| FI20010118L (fi) * | 2001-01-19 | 2002-07-20 | Carbion Oy | Uudet helicobacter pylori reseptorit ja niiden käyttö |
| CN1561389A (zh) * | 2001-07-25 | 2005-01-05 | 纽约大学 | 糖基神经酰胺作为用于抗传染病和癌症的疫苗的佐剂的用途 |
| WO2006093524A2 (en) * | 2004-07-16 | 2006-09-08 | The General Hospital Corporation | Antigen-carbohydrate conjugates |
| CA2577009C (en) | 2004-08-27 | 2017-05-02 | Albert Einstein College Of Medicine, Inc. | Ceramide derivatives as modulators of immunity and autoimmunity |
| US8022043B2 (en) | 2004-08-27 | 2011-09-20 | Albert Einstein College Of Medicine Of Yeshiva University | Ceramide derivatives as modulators of immunity and autoimmunity |
| GB0419846D0 (en) * | 2004-09-07 | 2004-10-13 | Chiron Srl | Vaccine adjuvants for saccharides |
| US7923013B2 (en) | 2004-12-28 | 2011-04-12 | The Rockefeller University | Glycolipids and analogues thereof as antigens for NKT cells |
| WO2007051004A2 (en) * | 2005-10-28 | 2007-05-03 | The Brigham And Women's Hospital, Inc. | Conjugate vaccines for non-proteinaceous antigens |
| CN102066394B (zh) * | 2007-10-12 | 2015-04-01 | 路易吉·潘扎 | 用作免疫佐剂的糖脂的类似物 |
| EP2058011A1 (en) * | 2007-11-07 | 2009-05-13 | Wittycell | Nkt cell activating gycolipids covalently bound antigens and/or drug |
| CN102355908B (zh) * | 2009-01-23 | 2014-09-24 | 德克萨斯大学系统评论委员会 | 纳米粒子制备的糖脂免疫抗原 |
| US8455565B2 (en) | 2011-05-18 | 2013-06-04 | 3M Innovative Properties Company | Disulfide monomers comprising ethylenically unsaturated groups suitable for dental compositions |
-
2013
- 2013-03-19 CN CN201380015125.5A patent/CN104321079A/zh active Pending
- 2013-03-19 WO PCT/EP2013/055719 patent/WO2013139803A1/en not_active Ceased
- 2013-03-19 RU RU2014142043A patent/RU2649009C2/ru active
- 2013-03-19 PT PT137104220T patent/PT2827899E/pt unknown
- 2013-03-19 SG SG11201405646TA patent/SG11201405646TA/en unknown
- 2013-03-19 BR BR112014023193A patent/BR112014023193A2/pt not_active Application Discontinuation
- 2013-03-19 ES ES13710422.0T patent/ES2551599T3/es active Active
- 2013-03-19 HU HUE13710422A patent/HUE028144T2/en unknown
- 2013-03-19 JP JP2015500890A patent/JP5933106B2/ja active Active
- 2013-03-19 TW TW102109653A patent/TWI633112B/zh not_active IP Right Cessation
- 2013-03-19 AU AU2013237497A patent/AU2013237497B2/en active Active
- 2013-03-19 HK HK15106209.7A patent/HK1205682A1/xx unknown
- 2013-03-19 MX MX2014011242A patent/MX337202B/es active IP Right Grant
- 2013-03-19 DK DK13710422.0T patent/DK2827899T3/en active
- 2013-03-19 SI SI201330079T patent/SI2827899T1/sl unknown
- 2013-03-19 CA CA2866978A patent/CA2866978C/en active Active
- 2013-03-19 EP EP13710422.0A patent/EP2827899B1/en active Active
- 2013-03-19 KR KR1020147029250A patent/KR101675657B1/ko active Active
- 2013-03-19 PL PL13710422T patent/PL2827899T3/pl unknown
- 2013-03-19 US US14/385,948 patent/US10588962B2/en active Active
- 2013-03-20 AR ARP130100898A patent/AR090386A1/es unknown
-
2014
- 2014-09-11 IL IL234604A patent/IL234604A/en active IP Right Grant
-
2015
- 2015-09-25 CY CY20151100848T patent/CY1116706T1/el unknown
-
2016
- 2016-04-27 JP JP2016089305A patent/JP6235648B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| IL234604A (en) | 2016-03-31 |
| HK1205682A1 (zh) | 2015-12-24 |
| MX337202B (es) | 2016-02-17 |
| TW201343662A (zh) | 2013-11-01 |
| CA2866978C (en) | 2019-01-29 |
| JP5933106B2 (ja) | 2016-06-08 |
| CA2866978A1 (en) | 2013-09-26 |
| SG11201405646TA (en) | 2014-10-30 |
| US10588962B2 (en) | 2020-03-17 |
| KR101675657B1 (ko) | 2016-11-11 |
| HUE028144T2 (en) | 2016-11-28 |
| MX2014011242A (es) | 2015-03-09 |
| EP2827899B1 (en) | 2015-08-05 |
| ES2551599T3 (es) | 2015-11-20 |
| JP2016183166A (ja) | 2016-10-20 |
| WO2013139803A1 (en) | 2013-09-26 |
| KR20140138996A (ko) | 2014-12-04 |
| RU2649009C2 (ru) | 2018-03-29 |
| TWI633112B (zh) | 2018-08-21 |
| AR090386A1 (es) | 2014-11-05 |
| JP2015514067A (ja) | 2015-05-18 |
| DK2827899T3 (en) | 2015-10-26 |
| EP2827899A1 (en) | 2015-01-28 |
| US20150238597A1 (en) | 2015-08-27 |
| SI2827899T1 (sl) | 2015-11-30 |
| RU2014142043A (ru) | 2016-05-20 |
| PT2827899E (pt) | 2015-11-18 |
| AU2013237497A1 (en) | 2014-10-02 |
| CN104321079A (zh) | 2015-01-28 |
| PL2827899T3 (pl) | 2015-12-31 |
| AU2013237497B2 (en) | 2016-05-12 |
| CY1116706T1 (el) | 2017-03-15 |
| JP6235648B2 (ja) | 2017-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014023193A2 (pt) | composto da fórmula geral (i): a[l-ch-ca]p e formulação de vacina | |
| EP2648520A4 (en) | DEXMEDETOMIDINVORMISCHUNGSFORMULIERUNG | |
| IL245328A0 (en) | Pharmaceutical composition | |
| DK3170508T3 (da) | Vaccineformuleringer | |
| DK2525798T3 (da) | Anæstetisk formulering | |
| PL2611310T3 (pl) | Formulacja antybakteryjna | |
| BR112015000420A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| DK3335652T3 (da) | Medicinsk fastgørelseselement | |
| HUE043091T2 (hu) | Immunogén készítmény | |
| EP2595653A4 (en) | INFLUENZA VACCINE | |
| EP2552212A4 (en) | IMPROVED FORMULATION | |
| EP2876161A4 (en) | VACCINE | |
| HUE044772T2 (hu) | Immunogén készítmény | |
| EP2825196A4 (en) | ADJUVANZ AND VACCINE COMPOSITIONS | |
| BR112014000015A2 (pt) | formulação | |
| EP2531023A4 (en) | IMPROVED FORMULATION | |
| LT2804611T (lt) | Chitozano darinių kompozicijos | |
| SMT202000288T1 (it) | Formulazione farmaceutica comprendente inositolo | |
| DK2868318T4 (da) | Injicerbar formulering | |
| EP2925338A4 (en) | LYOPHILIZED FORMULATION OF TAT-NR2B9C | |
| EP2815752A4 (en) | ORAL PHARMACEUTICAL COMPOSITION | |
| EP2919777A4 (en) | TRANSMUCOSAL ADMINISTRATION OF TOCOTRIENOL | |
| BR112013009948A2 (pt) | formulação de glifosato | |
| CO7010828A2 (es) | Preparación farmacéutica que comprende ßciclodextrina sustituida | |
| EP2815753A4 (en) | ORAL PHARMACEUTICAL COMPOSITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |